A newly discovered gene called double-time regulates the molecular cycles underlying circadian rhythms, scientists from The Rockefeller University report in two papers featured on the cover of the July 10 issue of Cell. The researchers also identified the molecular mechanism that allows this gene...

Noted Cancer Researcher Chosen to Succeed Torsten Wiesel as RU's Eighth Leader Dr. Arnold J. Levine, the Harry C. Wiess Professor in the Life Sciences at Princeton University and a world-renowned cancer biologist, has been elected the eighth president of The Rockefeller University. Dr. Levine was...

Award from The Rockefeller University recognizes scientists as poets Evolutionary biologist and author Ernst Mayr, Ph.D., is the recipient of the 1998 Lewis Thomas Prize: Honoring the Scientist as Poet. The prize, which honors scientists for their literary achievements, is awarded by The Rockefel...

The Rockefeller University is looking for people with type 2 diabetes to participate in a study aimed at determining the genetic causes of early- and late-onset forms of the disease. The study is part of the research program of the university's Starr Center for Human Genetics. "We hope that by id...

Researchers from The Rockefeller University in New York City have developed a new method to fight cancer by using dendritic cells to activate T cells via a new pathway. Reported in the March 5 Nature, the technique offers the promise of new therapies for cancer, AIDS and autoimmune diseases. "We'...

$5 million gift from university trustee launches new initiative The Rockefeller University will launch the Christopher H. Browne Center for Immunology and Immune Diseases with a $5 million gift from university Trustee Christopher H. Browne, managing director of the investment firm Tweedy Browne C...

Please refer to the following link: http://www.cfah.org/

Nobel Prize winner Bruce Merrifield, Ph.D., John D. Rockefeller Jr. Professor Emeritus at The Rockefeller University, has been named one of the top 75 "distinguished contributors to the chemical enterprise" by Chemical & Engineering News (C&EN), the news magazine of the American Chemical Society,...

Finding may provide a direction for new diabetes therapies A defect in a gene recently linked to a rare inherited form of Type 2 diabetes impairs the pathway that breaks down blood sugar and provides the main signal for insulin secretion in the pancreas, report researchers at The Rockefeller Univ...

Three therapies derived from plants will be tested at The Rockefeller University in New York City for their ability to prevent colorectal cancer, which afflicts some 150,000 Americans each year. The compounds have the potential to be safer than cancer-thwarting nonsteroidal antiinflammatory drugs...